Simplex Trading
LCTX icon

Simplex Trading’s Lineage Cell Therapeutics LCTX Stock Holding History

Simplex Trading’s Portfolio LCTX Stock Details LCTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.32K Buy
+2,100
New +$3.54K ﹤0.01% 8126
2023
Q1 		– Sell
-2,000
Closed -$2K – 9619
2022
Q4 		$2K Hold
2,000
– – ﹤0.01% 8598
2022
Q3 		$2K Buy
+2,000
New +$2.94K ﹤0.01% 9300
2022
Q2 		– Sell
-6,000
Closed -$9K – 10563
2022
Q1 		$9K Sell
6,000
-4,900
-45% -$7.6K ﹤0.01% 8961
2021
Q4 		$26K Sell
10,900
-16,900
-61% -$39.6K ﹤0.01% 8085
2021
Q3 		$79K Hold
27,800
– – ﹤0.01% 6948
2021
Q2 		$79K Buy
27,800
+27,067
+3,693% +$70K ﹤0.01% 7063
2021
Q1 		$172K Buy
733
+636
+656% +$1.53K ﹤0.01% 4973
2020
Q4 		$17K Buy
97
+76
+362% +$106 ﹤0.01% 7077
2020
Q3 		$1K Buy
+21
New +$19 ﹤0.01% 7570
2020
Q1 		– Sell
-33
Closed -$2K – 7944
2019
Q4 		$2K Buy
+33
New +$27 ﹤0.01% 6977
2018
Q3 		– Sell
-23
Closed -$4K – 7748
2018
Q2 		$4K Buy
+23
New +$46 ﹤0.01% 6807
2017
Q4 		– Sell
-16
Closed -$1K – 6340
2017
Q3 		$1K Buy
16
+3
+23% +$7 ﹤0.01% 5472
2017
Q2 		$1K Buy
+13
New +$36 ﹤0.01% 5640
2016
Q4 		– Sell
-7
Closed -$2K – 6211
2016
Q3 		$2K Hold
7
– – ﹤0.01% 4968
2016
Q2 		$2K Buy
+7
New +$17 ﹤0.01% 4949
2015
Q3 		– Sell
-36
Closed -$4K – 5862
2015
Q2 		$4K Buy
+36
New +$140 ﹤0.01% 3822

Other funds holding LCTX

BC
Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DC
Defender Capital Charlotte, North Carolina $308M AUM 4.52% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
RA
Raffles Associates New York $115M AUM 35.69% 1-Year Est. Return
Fifth Third Bancorp
Fifth Third Bancorp Cincinnati, Ohio $54.7B AUM 26.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Simplex Trading's LCTX Position: Q1 2026 in Review

Simplex Trading opened a new position in Lineage Cell Therapeutics (LCTX) in Q1 2026: 9,698 shares worth $15.3K. The stake represents ﹤0.01% of the portfolio and ranks #6977 among its holdings. This is a return to the name: Simplex Trading previously reported a position in LCTX as recently as Q3 2025.

Simplex Trading first reported a position in LCTX in Q2 2015 and has held it in 31 quarters since. The position peaked at $168K in Q1 2021. 130 funds tracked by Wall St. Rank hold LCTX as of Q1 2026.

  • Simplex Trading held 9,698 shares of Lineage Cell Therapeutics worth $15.3K as of Q1 2026.
  • Lineage Cell Therapeutics was a new Simplex Trading position in Q1 2026.
  • Lineage Cell Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #6977 holding.
  • Simplex Trading first reported a position in Lineage Cell Therapeutics in Q2 2015 and has held it in 31 quarters since.
  • Simplex Trading's Lineage Cell Therapeutics position peaked at $168K in Q1 2021.
  • 130 funds tracked by Wall St. Rank held Lineage Cell Therapeutics as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.